Literature DB >> 19048600

Lymph node assessment in cervical cancer: prognostic and therapeutic implications.

L T Gien1, A Covens.   

Abstract

Lymph node status is not part of the staging system for cervical cancer, but provides important information for prognosis and treatment. This article reviews the incidence and patterns of lymph node metastasis, and the issues surrounding surgical assessment of lymph nodes. The preoperative assessment of lymph nodes by imaging, as well as the intraoperative assessment by sentinel nodes will be discussed. Finally, the prognostic and therapeutic implications of lymphadenectomy in cervical cancer will be reviewed.

Entities:  

Mesh：

Year:  2009        PMID： 19048600     DOI： 10.1002/jso.21199

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  26 in total

Review 1.  Progress in the Study of Lymph Node Metastasis in Early-stage Cervical Cancer.

Authors:  Bang-Xing Huang; Fang Fang
Journal:  Curr Med Sci       Date:  2018-08-20

2.  Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.

Authors:  Helen J Mackay; Lari Wenzel; Linda Mileshkin
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

3.  Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.

Authors:  Tetsushi Tsuruga; Asaha Fujimoto; Kei Kawana; Mayuyo Mori; Yoko Hasumi; Nao Kino; Kensuke Tomio; Shiho Miura; Michihiro Tanikawa; Kenbun Sone; Yuichiro Miyamoto; Yuji Ikeda; Satoko Kojima; Katsuyuki Adachi; Kazunori Nagasaka; Yoko Matsumoto; Takahide Arimoto; Katsutoshi Oda; Shunsuke Nakagawa; Koji Horie; Toshiharu Yasugi; Harushige Yokota; Yutaka Osuga; Tomoyuki Fujii
Journal:  Int J Clin Oncol       Date:  2015-10-05       Impact factor: 3.402

4.  Development of a deep learning-based nomogram for predicting lymph node metastasis in cervical cancer: A multicenter study.

Authors:  Yujia Liu; Hui Duan; Di Dong; Jiaming Chen; Lianzhen Zhong; Liwen Zhang; Runnan Cao; Huijian Fan; Zhumei Cui; Ping Liu; Shan Kang; Xuemei Zhan; Shaoguang Wang; Xun Zhao; Chunlin Chen; Jie Tian
Journal:  Clin Transl Med       Date:  2022-07

5.  Histogram analysis of apparent diffusion coefficients for predicting pelvic lymph node metastasis in patients with uterine cervical cancer.

Authors:  Jiyeong Lee; Chan Kyo Kim; Sung Yoon Park
Journal:  MAGMA       Date:  2019-09-23       Impact factor: 2.310

6.  A novel 2-deoxy-2-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT)-based nomogram to predict lymph node metastasis in early stage uterine cervical squamous cell cancer.

Authors:  Shuai Liu; Zheng Feng; Jiajia Zhang; Huijuan Ge; Xiaohua Wu; Shaoli Song
Journal:  Quant Imaging Med Surg       Date:  2021-01

7.  Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS.

Authors:  Toon Van Gorp; Isabelle Cadron; Anneleen Daemen; Bart De Moor; Etienne Waelkens; Ignace Vergote
Journal:  Proteome Sci       Date:  2012-06-13       Impact factor: 2.480

8.  Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer.

Authors:  Xiaojuan Lv; Lu Chen; Hua Yu; Xiang Zhang; Dingding Yan
Journal:  Arch Gynecol Obstet       Date:  2011-08-12       Impact factor: 2.344

9.  Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? A large-scale retrospective study.

Authors:  Ting Hu; Xiong Li; Qinghua Zhang; Kecheng Huang; Yao Jia; Ru Yang; Fangxu Tang; Qiang Tian; Ding Ma; Shuang Li
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

10.  Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics.

Authors:  W Wang; H-L Jia; J-M Huang; Y-C Liang; H Tan; H-Z Geng; L-Y Guo; S-Z Yao
Journal:  Br J Cancer       Date:  2014-02-25       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.